BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1229 related articles for article (PubMed ID: 19635560)

  • 41. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses.
    Kitazawa Y; Fujino M; Wang Q; Kimura H; Azuma M; Kubo M; Abe R; Li XK
    Transplantation; 2007 Mar; 83(6):774-82. PubMed ID: 17414712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD).
    Cao T; Soto A; Zhou W; Wang W; Eck S; Walker M; Harriman G; Li L
    Cell Immunol; 2009; 258(1):65-71. PubMed ID: 19410243
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adoptive transfer of CD4+CD25+ regulatory cells combined with low-dose sirolimus and anti-thymocyte globulin delays acute rejection of renal allografts in Cynomolgus monkeys.
    Ma A; Qi S; Song L; Hu Y; Dun H; Massicotte E; Dupuis M; Daloze P; Chen H
    Int Immunopharmacol; 2011 May; 11(5):618-29. PubMed ID: 21094689
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dendritic cells induce regulatory T cell proliferation through antigen-dependent and -independent interactions.
    Zou T; Caton AJ; Koretzky GA; Kambayashi T
    J Immunol; 2010 Sep; 185(5):2790-9. PubMed ID: 20686126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Feedback loop of immune regulation by CD4+CD25+ Treg.
    Jung YJ; Seoh JY
    Immunobiology; 2009; 214(4):291-302. PubMed ID: 19327546
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo induction of type 1-like regulatory T cells using genetically modified B cells confers long-term IL-10-dependent antigen-specific unresponsiveness.
    Ahangarani RR; Janssens W; VanderElst L; Carlier V; VandenDriessche T; Chuah M; Weynand B; Vanoirbeek JA; Jacquemin M; Saint-Remy JM
    J Immunol; 2009 Dec; 183(12):8232-43. PubMed ID: 20007587
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Suppression of alloimmunity in mice by regulatory T cells converted with conditioned media.
    Teng L; Liu L; Su Y; Yuan X; Li J; Fu Q; Chen S; Wang C
    J Surg Res; 2011 Dec; 171(2):797-806. PubMed ID: 20538297
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Infusion of ex vivo expanded homologous CD4⁺;CD25⁺; regulatory T cells promotes the susceptibility to tumor in mice].
    Guo T; Luo S; Xu J; Dai J; Liu Z; Gao X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):466-70. PubMed ID: 24796739
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tolerogenic semimature dendritic cells induce effector T-cell hyporesponsiveness by the activation of antigen-specific CD4+ CD25+ T-regulatory cells.
    Fu BM; He XS; Yu S; Hu AB; Ma Y; Wu LW; Tam NL; Huang JF
    Exp Clin Transplant; 2009 Sep; 7(3):149-56. PubMed ID: 19715524
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacologic expansion of donor-derived, naturally occurring CD4(+)Foxp3(+) regulatory T cells reduces acute graft-versus-host disease lethality without abrogating the graft-versus-leukemia effect in murine models.
    Duramad O; Laysang A; Li J; Ishii Y; Namikawa R
    Biol Blood Marrow Transplant; 2011 Aug; 17(8):1154-68. PubMed ID: 21145405
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mapping of the lingual immune system reveals the presence of both regulatory and effector CD4+ T cells.
    Mascarell L; Lombardi V; Zimmer A; Louise A; Tourdot S; Van Overtvelt L; Moingeon P
    Clin Exp Allergy; 2009 Dec; 39(12):1910-9. PubMed ID: 19694757
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recipient-Derived Allo-iTregs Induced by Donor DCs Effectively Inhibit the Proliferation of Donor T Cells and Reduce GVHD.
    Yang ZG; Wen RT; Feng JS; Cao PJ; Zhou HT; Liu WX
    Anat Rec (Hoboken); 2019 May; 302(5):825-836. PubMed ID: 30312018
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance.
    Li XL; Ménoret S; Bezie S; Caron L; Chabannes D; Hill M; Halary F; Angin M; Heslan M; Usal C; Liang L; Guillonneau C; Le Mauff B; Cuturi MC; Josien R; Anegon I
    J Immunol; 2010 Jul; 185(2):823-33. PubMed ID: 20543104
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice.
    Suffner J; Hochweller K; Kühnle MC; Li X; Kroczek RA; Garbi N; Hämmerling GJ
    J Immunol; 2010 Feb; 184(4):1810-20. PubMed ID: 20083650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intravenous immunoglobulin attenuates airway inflammation through induction of forkhead box protein 3-positive regulatory T cells.
    Massoud AH; Guay J; Shalaby KH; Bjur E; Ablona A; Chan D; Nouhi Y; McCusker CT; Mourad MW; Piccirillo CA; Mazer BD
    J Allergy Clin Immunol; 2012 Jun; 129(6):1656-65.e3. PubMed ID: 22564681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis.
    Sun JB; Czerkinsky C; Holmgren J
    J Immunol; 2012 Feb; 188(4):1686-97. PubMed ID: 22250081
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of dendritic cells via TLR7 reduces Foxp3 expression and suppressive function in induced Tregs.
    Hackl D; Loschko J; Sparwasser T; Reindl W; Krug AB
    Eur J Immunol; 2011 May; 41(5):1334-43. PubMed ID: 21469103
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis.
    Dinh TN; Kyaw TS; Kanellakis P; To K; Tipping P; Toh BH; Bobik A; Agrotis A
    Circulation; 2012 Sep; 126(10):1256-66. PubMed ID: 22851544
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neutrophil elastase treated dendritic cells promote the generation of CD4(+)FOXP3(+) regulatory T cells in vitro.
    Tateosian NL; Reiteri RM; Amiano NO; Costa MJ; Villalonga X; Guerrieri D; Maffía PC
    Cell Immunol; 2011; 269(2):128-34. PubMed ID: 21477798
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of in vitroexpanded CD4(+)CD25(+)Foxp3(+) regulatory T cell therapy combined with lymphodepletion in murine skin allotransplantation.
    Park YH; Koo SK; Kim Y; Kim HM; Joe IY; Park CS; Kim SC; Han DJ; Lim DG
    Clin Immunol; 2010 Apr; 135(1):43-54. PubMed ID: 20006940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.